Prognostic value of tumor mutation burden (TMB) and INDEL burden (IDB) in cancer: current view and clinical applications
Ann Transl Med
.
2020 May;8(9):575.
doi: 10.21037/atm-2020-75.
Authors
Anwaar Saeed
1
,
Mohamed E Salem
2
Affiliations
1
Department of Medicine, Division of Medical Oncology, Gastrointestinal Oncology Program, Kansas University Cancer Center, Kansas City, KS, USA.
2
Department of solid tumor oncology, Levine Cancer Institute, Charlotte, NC, USA.
PMID:
32566602
PMCID:
PMC7290524
DOI:
10.21037/atm-2020-75
No abstract available
Publication types
Editorial
Comment